Similarly, when patients with MOG-AD develop atypical symptoms, such as psychosis, seizures, and dyskinesia, coexistence of anti-NMDARe should be considered.[1,10] This case highlighted the importance of comprehensive screening for autoantibodies to identify unusual autoimmune diseases. The gene discussed is MOG; the disease is drug-induced dyskinesia.